New drugs could reach market sooner as govt halves trial review timeline

›
The Indian government is shaking up the pharmaceutical sector by slashing the review period for manufacturing applications for new drugs to ...

Bastar's first super-specialty hospital opens

›
Bastar region will soon have its first super specialty hospital. Located in Jagdalpur, the facility opens in February. Hyderabad-based Conti...

Budget 2026: Industry leaders seek funding framework for innovation, R&D in pharma, MedTech

›
Industry leaders are calling for a structured funding framework in the upcoming Union Budget. This aims to boost innovation and R&D in I...

Zydus launches biosimilar for treatment of multiple cancers

›
Zydus Lifesciences has launched Tishtha, the world's first biosimilar of Nivolumab, in India. This drug treats multiple cancers. Tishtha...

Over 160 drug samples found sub-standard in December

›
A recent inspection by India's drug regulator has revealed a troubling statistic: 167 medication samples were classified as not of stand...

CDSCO finds over 160 drug samples as 'not of standard quality' for December

›
In December 2025, 74 drug samples were identified as Not of Standard Quality (NSQ) by Central Drugs Laboratories and 93 by State Drugs Testi...

Drug maker Lupin inks licensing pact with Galenicum for injectable Semaglutide

›
Drug maker Lupin announced a significant partnership. Its subsidiary, Lupin Atlantis Holdings SA, has signed an agreement with Galenicum Hea...